Top 6 Biotechs To Buy After The Recent Sell-off

The high beta biotech sector has started to reverse after being one of the market leaders since its last sell-off at the end of the first quarter of 2014. This “risk off” sector rotation could continue until the overall market finds firmer footing.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.